2016
DOI: 10.1097/ypg.0000000000000148
|View full text |Cite
|
Sign up to set email alerts
|

Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16–20 October 2015

Abstract: The XXIIIrd World Congress of Psychiatric Genetics (WCPG) meeting, sponsored by the International Society of Psychiatric Genetics (ISPG), was held in Toronto, ON, Canada, on October 16-20, 2015. Approximately 700 participants attended to discuss the latest state-of-the-art findings in this rapidly advancing and evolving field. The following report was written by trainee travel awardees. Each was assigned one session as a rapporteur. This manuscript represents the highlights and topics that were covered in the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 67 publications
(73 reference statements)
0
1
0
Order By: Relevance
“…This suggests that alterations in stress-induced changes of endocytosis could contribute to disease risk by altering neuronal activity. For example, glutamate receptor turnover has been shown to be altered by glucocorticoid-induced enhancement of ubiquitin/proteasome-mediated degradation of receptor subunits 37 , a process localized to late endosomes and multivesicular membranes 38,39 . Pathway analyses revealed enrichment for cytoplasmic ribosomal proteins; ribosomal protein have been shown to be altered both in postmortem gene expression studies for MDD and SCZ 36 , as well as in pluripotent stem cell-derived neural progenitor cells 40 or olfactory-derived neuroepithelial cells 41 from patients with SCZ.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that alterations in stress-induced changes of endocytosis could contribute to disease risk by altering neuronal activity. For example, glutamate receptor turnover has been shown to be altered by glucocorticoid-induced enhancement of ubiquitin/proteasome-mediated degradation of receptor subunits 37 , a process localized to late endosomes and multivesicular membranes 38,39 . Pathway analyses revealed enrichment for cytoplasmic ribosomal proteins; ribosomal protein have been shown to be altered both in postmortem gene expression studies for MDD and SCZ 36 , as well as in pluripotent stem cell-derived neural progenitor cells 40 or olfactory-derived neuroepithelial cells 41 from patients with SCZ.…”
Section: Discussionmentioning
confidence: 99%